Shepard KV:Dyspnea in cancer patients. PCL Review, 1990;2(6):insert 1-1
2.
Gift AG: Dyspnea. Nurs Clin North Am, 1990;25(4):955-965
3.
Reuben DB, Mor V:Dyspneain terminally ill cancer patients. Chest, 1986;89:234-236
4.
Bruera E, Macmillan K, Pither J,et. al: Effects of morphine on the dyspnea of terminal cancer patients. JPain Symptom Manage,1990;5:341-344
5.
Coyle N, Adelhardt J, Foley KM: Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage, 1990;5:83-93
6.
Ventafridda V, Spoldi E, DeConno F: Control of dyspnea in advanced cancer patients [letter]. Chest, 1990;98(6): 1544-1545
7.
Saunders C: Hospice Care. Am JMed, 1978;65:726-728
Solomon EP, Davis PW: Human anatomy and physiology. Saunders College Publishing, Philadelphia, 1983:540-569
10.
Dantzker DR,Tobin MJ:Anatomical and physiological considerations. In: Andreoli TE, Carpenter CCJ,Plum F, Smith LH (eds.): Cecil essentials of medicine. WB Saunders, Co, Philadelphia, 1990:126-135
11.
Freedman S: facial cooling and perception of dyspnoea. Lancet, 1987;l:1215-1215
12.
Janson-Bjerklie S. Carrieri VK, Hudes M: The sensations of pulmonary dyspnea. Nurs Res, 1987;35:154-159
13.
Dales RE, Spitzer WO, Schechter MT. et al: The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis, 1989;139:1459-1463
14.
Gift AG, Plaut SM, Jacox A: Psychologic and physiologic factors related to dyspnea in subjects with chronic obstructive pulmonary disease. Heart and Lung, 1986;15:595-601
15.
Carrieri VK, Janson-Bjerklie S: Strategies patients use to manage the sensation of dyspnoea. West JNurs Res, 1986;8:284-305
16.
Brown ML, Carneri V, Janson-Bjerklie S.et al: Lung cancer and dyspnea: the patient's perception, On col Nurs Forum, 1986;13:19-24
17.
Cowcher K, Hanks GW: Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage, 1990;5:320-330
18.
Light RW, Muro JR. Sato RJ, et al: Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Resp Dis, 1989; 139:126-133
19.
Cohen MH, Anderson AJ, Krasnow SH, et al: Continuous intravenous infusion of morphine for severe dyspnea. South Med J, 1991;84:229-234
20.
Johanson GA: Should opioids or sedatives beused for dyspnea in end-stage disease?Am J Hospice & Pall Care, 1990;July/August:12-13
21.
Mitchell-Heggs P, Murphy K, Minty K, et al: Diazepam in the treatment ofdyspnea in the “pink puffer” syndrome. QJMed, 1980;193:9-20
22.
Greene JG, Pucino F, Carison JD, et al: Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study. Pharmacotherapy, 1989;9(1):34-38
23.
Woodcock AA, Gross ER, Geddes DM: Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. B Med J,1981;283:343-346
24.
Man GCW, Hsu K, Sproule BJ: Effect of alprazolam on exercise and dyspnea inpatients with chronic obstructive pulmonary disease. Chest, 1986;90(6):832-836
25.
Twycross RG: The measurement of pain in terminal carcinoma.J Int Med Res, 1976;4(2):59-67
26.
Billings JA: The management of common symptoms. In: Billings JA (ed.): Outpatient management of advanced cancer. JB Lippincott Co., Philadelphia, 1985:80-84
27.
Levy MH, Catalano RB: Control ofcommon symptoms other than pain in patients with terminal disease. Seminars in Oncology, 1985;12(4):411-430
28.
Farr WC:The use of corticosteroids for symptom management in terminally illpatients. Am J Hosp Care, 1990;Jan-Feb:41-46
29.
Bruera E, Roca E, Cedaro L et al: Action of oral methylprednisolone in terminal cancer patients: a prospective randomized doubleblind study. Cancer Treat Rep, 1985;69:751-754
30.
Stark RD, O'Neill PA, Russell JW et al: Effects of small-particle aerosols of local anesthetic on dyspnea in patients with respiratory disease. Clin Sci, 1985;69:29-36
31.
Winning AJ, Hamilton RD, Shea SA et al: The effect of airway anesthesia on the control of breathing and the sensation of breathlessness in man. Clin Sci, 1985;68:215-225
32.
Santolicandro A, Petruzzelli S, Guitini C: Effects of lidocaine aerosol on dyspnea in emphysematous patients. Clin Resp Physio, 1983;l9:41P-42P
33.
Winning AJ, Hanulton RD, Guz A: Ventilation and breathlessness on maximal exercise in patients with interstitial lung disease after local anesthetic aerosol inhalation. Clin Sci, 1988;74:275-281
34.
Kaye P: Notes on symptom control in hospice and palliative care. Essex: Hospice Education Institute, 1989;115-159
35.
McAlpine LG, Thomson NC: Bronchoconstriction induced by nebulized lignocaine in asthmatic patients. Thorax, 1988;43:260P-260P
